Pendulum Therapeutics is a company focused on developing clinically validated microbiome interventions. They offer proprietary probiotic strains, including live Akkermansia, aimed at improving metabolic health and managing conditions such as type 2 diabetes. Their approach is grounded in rigorous scientific research and clinical trials, often in partnership with established institutions like the Mayo Clinic. Pendulum's products are designed to support gut health, reduce blood sugar levels, and enhance energy metabolism, providing unique solutions to managing specific health concerns.